Latest filing published 20 Jan 2022 for Ikena Oncology, Inc., €100k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Maude Tessier: trading record in brief
All filings by Maude Tessier on record concern ImageneBio, Inc., in the capacity of senior executive. The record holds 3 filings, all for trades on 18 January 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 20 January 2022, reports an option exercise of €89k in ImageneBio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Maude Tessier
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 38,915 shares@ US$2.94100.0% of flowCommon StockSEC:0000899243-22-002657:0
1 of 1 declaration